Pulmonary Hamartoma


Article Author:
Kristina Lundeen
Moses Raj


Article Editor:
Dipesh Ludhwani


Editors In Chief:
Juan Batlle
Jitendra Sisodia
Jeffrey Miller


Managing Editors:
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Frank Smeeks
Kristina Soman-Faulkner
Benjamin Eovaldi
Radia Jamil
Sobhan Daneshfar
Saad Nazir
William Gossman
Pritesh Sheth
Hassam Zulfiqar
Navid Mahabadi
Steve Bhimji
John Shell
Matthew Varacallo
Ahmad Malik
Mark Pellegrini
James Hughes
Beata Beatty
Hajira Basit
Phillip Hynes


Updated:
5/6/2019 12:22:04 AM

Introduction

A lesion first described by German pathologist Eugen Albrecht in 1904, hamartomas are generally benign tumors that may occur in the lungs, skin, heart, breast and other regions of the body. The word hamartoma derives from “hamartia,” the Greek word for ‘erroneous,” or “faulty."[1] The cellular make-up of a hamartoma is that of an abnormal mixture of tissue components that are common in the organ of origin, though organ architecture is usually not preserved within the lesion.

Pulmonary hamartomas can, therefore, be viewed as benign malformations of common lung tissue, to include cartilage, epithelium, fat, or muscle. They are the most common benign pulmonary neoplasm in adults. However, they are much more rare in children.[2][3] These lesions are usually located in the peripheral parenchyma but have in rare cases been present in the central chest wall. Lesions tend to grow at the same rate as the surrounding tissue. Therefore neoplastic pressure erosion of adjacent structures is typically not noted.

Etiology

Historically, no specific risk factors have been identified for pulmonary hamartoma. Occasionally, a relationship between lesions that have undergone sarcomatous transformation and specific genomic alterations has been described,[4] but there are currently no screening guidelines specifically designed for the early diagnosis of pulmonary hamartoma. 

Epidemiology

Pulmonary hamartomas occur with an incidence of 0.025 to 0.032% within the adult population. They usually present in the fifth and sixth decade of life, with males being four times more likely to be affected than females.[3]  Although still an uncommon occurrence, these lesions are the most common benign pulmonary neoplasm, accounting for an estimated 77% of benign lung nodules and 8% of solitary lung lesions.[2][5] Most hamartomas occur in the peripheral parenchyma, with exceptions observed in the central chest wall. Additionally, approximately 10 % of lesions present endobronchially.[2][6] Within the pediatric population, pulmonary hamartomas are significantly rarer.[3]

Histopathology

Also known as chondroid hamartomas, the histological makeup of these tumors is a mixture of mature mesenchymal tissue, like adipose tissue, cartilage, bone, or smooth muscle bundles, and fibromyxoid tissue, with varying proportions of each component. They are non-invasive, slow-growing, nodular lesions, sometimes displaying cleft-like spaces within, lined by respiratory epithelium.[3]

History and Physical

In adults the majority of parenchymal hamartomas produce no symptoms, often being incidental findings. Depending on the location and size of the lesion, however, patients can still develop an array of complaints, including persistent coughing or wheezing, dyspnea, hemoptysis, rhonchi, higher likelihood of pneumonia, atelectasis or even pneumothorax. Endobronchial masses additionally pose the danger of airway obstruction. Hamartomas that have become symptomatic require a thorough diagnostic approach, and surgical resection can become necessary.[3][7]

Evaluation

Hamartomas are often incidental findings on imaging and can mimic pulmonary malignancies. Once found, or in the case of asymptomatic hamartoma, there are multiple diagnostic strategies available to determine the nature of the lesion. On imaging, e.g., chest X-ray or CT scans, masses present as coin- shaped and solitary, with well-defined edges, typically measuring less than 4 cm in diameter. Calcification is present in 25% to 30% of patients. The “popcorn” or “comma-shaped” appearance of calcification is pathognomonic for hamartomas.[8][5] While CT imaging remains the gold-standard, further diagnostic measures can become necessary. FDG-PET scan can be useful to determine the rate of FDG uptake, and therefore metabolic rate, of lesions with an indeterminate risk of malignancy.[5] Especially in the case of lesions with an absent adipose component, or those lacking the characteristic calcification pattern, biopsy becomes mandatory to rule out underlying malignancy. Bronchoscopy with fine needle aspiration (FNA) is commonly the strategy of choice, though aspirations can be scant due to the density of the lesions.  Masses with the typical coin appearance that fulfill CT criteria for hamartoma (less than 4cm in size, well-defined edges, detectable calcification or fatty component) should remain subject to conservative follow up with periodical observation. Resection is reserved for fast-growing or symptomatic masses or those in which the possibility of malignancy cannot be excluded.[9][10]

Treatment / Management

Surgery remains the only definitive curative option available. In the event of surgery, preservation of functional lung tissue is the primary goal. Therefore, enucleation and wedge resections are the most common surgical choice, with more radical lobectomy or total pneumonectomy reserved for particularly deep lesions, multiple or large lesions that are making wedge resection impossible, or lesions adhering severely to the hilum of the lung. To avoid overlooking underlying malignant potential, obtaining intraoperative frozen sections is generally recommended.[11]

Differential Diagnosis

The most significant consideration when encountering a possible hamartomatous lesion should go to distinguishing the lesion from and excluding the possibility of underlying malignancy. Upon exclusion of malignancy, other benign pulmonary tumors should be considered when deliberating the nature of a solitary pulmonary nodule, to include infectious granuloma, lipoma, lipoid pneumonia, or pulmonary papilloma.[12] Also, though 90% are solitary occurrences, pulmonary hamartomas can also appear in association with genetic syndromes.[5] Multiple pulmonary chondromatous hamartomas have been noted as manifestations of either the Carney triad or Cowden syndrome. The former is predominantly seen in young women and characterized by the concurrent appearance of gastric leiomyoblastoma, pulmonary hamartoma, and extra-adrenal paraganglioma. Patients with Cowden disease often display multiple hamartomas, manifesting as mucocutaneous lesions, multiple benign tumors of internal organs and an increased risk for several forms of cancer, including breast and digestive tract malignancies.[13][14]

Prognosis

The prognosis for patients with lung hamartoma is generally excellent. Lesions are slow-growing and, in cases where symptoms are present and persistent, surgery is curative. Malignant transformation or subsequent malignancy are rare occurrences, and if patients adhere to a conservative observation schedule, are likely to be diagnosed early on.[3][11]

Complications

Beyond the possibility of airway obstruction, with subsequent atelectasis or recurrent pneumonia, pulmonary hamartomas have in rare cases been noted to bear potential for sarcomatous transformation. Common signs of malignant alteration are the rapid growth of the lesion and systemic symptoms like weight loss, weakness or fatigue. Histologically, this malignant change may not always be apparent, however macroscopic signs, like an invasion of adjacent tissue or distant metastases may be present. In some cases, a possible relationship between the presence of genomic abnormalities of 12q14 and 6q21, encoding the high mobility group A (HMGA), and the occurrence of pulmonary hamartoma has been observed. Also, incidence rates of lung cancer have been reported to be six times higher in patients with pulmonary hamartomas than in healthy subjects, making genetic predisposition to either malignant change or subsequent development of malignancy a possibility.[4][15]

Deterrence and Patient Education

There are no risk factors associated with the development of pulmonary hamartomas, nor are there defined screening guidelines, considering the mostly sporadic nature of the lesions. Considering the risk, albeit small, of malignant change and development of subsequent malignancy, patients should be advised to adhere to a schedule conservative observation in the form of periodical imaging and comparison with previous results.[11][4][15]

Enhancing Healthcare Team Outcomes

Patients with lung lesions often first come to the attention of the primary care provider and nurse practitioner. Because there is always the possibility of malignancy, these patients should obtain a referral to a multidisciplinary team that includes an oncologist, thoracic surgeon, radiologist, and a pulmonologist. If observation is deemed to be the management plan, the most important facet is to ensure that the lesion is not malignant. No matter how technically skilled the radiologist is interpreting lung lesions, the definitive diagnosis is only possible with a biopsy. If observation is the chosen course, serial CT scans are recommended to ensure that the lesion is not growing.


  • Image 8739 Not availableImage 8739 Not available
    Image courtesy S Bhimji MD
Attributed To: Image courtesy S Bhimji MD

Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Pulmonary Hamartoma - Questions

Take a quiz of the questions on this article.

Take Quiz
Which of the following is the most common benign tumor of the lungs?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is not a usual feature of hamartoma?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following statements about hamartomas is not true?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is NOT a feature of a hamartoma?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Select the true statement about pulmonary hamartomas.



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is true regarding pulmonary hamartomas on computerized tomography?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Pulmonary Hamartoma - References

References

Leiter Herrán F,Restrepo CS,Alvarez Gómez DI,Suby-Long T,Ocazionez D,Vargas D, Hamartomas from head to toe: an imaging overview. The British journal of radiology. 2017 Mar;     [PubMed]
Ahmed S,Arshad A,Mador MJ, Endobronchial hamartoma; a rare structural cause of chronic cough. Respiratory medicine case reports. 2017;     [PubMed]
Saadi MM,Barakeh DH,Husain S,Hajjar WM, Large multicystic pulmonary chondroid hamartoma in a child presenting as pneumothorax. Saudi medical journal. 2015 Apr;     [PubMed]
Itoga M,Kobayashi Y,Takeda M,Moritoki Y,Tamaki M,Nakazawa K,Sasaki T,Konno H,Matsuzaki I,Ueki S, A case of pulmonary hamartoma showing rapid growth. Case reports in medicine. 2013;     [PubMed]
Lu Z,Qian F,Chen S,Yu G, Pulmonary hamartoma resembling multiple metastases: A case report. Oncology letters. 2014 Jun;     [PubMed]
Kishore M,Gupta P,Preeti,Deepak D, Pulmonary Hamartoma Mimicking Malignancy: A Cytopathological Diagnosis. Journal of clinical and diagnostic research : JCDR. 2016 Nov;     [PubMed]
Ge F,Tong F,Li Z, Diagnosis and treatment of pulmonary hamartoma. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih. 1998 Mar;     [PubMed]
Radosavljevic V,Gardijan V,Brajkovic M,Andric Z, Lung hamartoma--diagnosis and treatment. Medical archives (Sarajevo, Bosnia and Herzegovina). 2012;     [PubMed]
Ribet M,Jaillard-Thery S,Nuttens MC, Pulmonary hamartoma and malignancy. The Journal of thoracic and cardiovascular surgery. 1994 Feb;     [PubMed]
Singh H,Khanna SK,Chandran V,Jetley RK, PULMONARY HAMARTOMA. Medical journal, Armed Forces India. 1999 Jan;     [PubMed]
Guo W,Zhao YP,Jiang YG,Wang RW,Ma Z, Surgical treatment and outcome of pulmonary hamartoma: a retrospective study of 20-year experience. Journal of experimental     [PubMed]
Khan AN,Al-Jahdali HH,Irion KL,Arabi M,Koteyar SS, Solitary pulmonary nodule: A diagnostic algorithm in the light of current imaging technique. Avicenna journal of medicine. 2011 Oct;     [PubMed]
Bini A,Grazia M,Petrella F,Chittolini M, Multiple chondromatous hamartomas of the lung. Interactive cardiovascular and thoracic surgery. 2002 Dec;     [PubMed]
Rodriguez FJ,Aubry MC,Tazelaar HD,Slezak J,Carney JA, Pulmonary chondroma: a tumor associated with Carney triad and different from pulmonary hamartoma. The American journal of surgical pathology. 2007 Dec;     [PubMed]
Basile A,Gregoris A,Antoci B,Romanelli M, Malignant change in a benign pulmonary hamartoma. Thorax. 1989 Mar;     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Radiology-Thoracic. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Radiology-Thoracic, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Radiology-Thoracic, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Radiology-Thoracic. When it is time for the Radiology-Thoracic board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Radiology-Thoracic.